Entasis Therapeutics Holdings
Waltham, US · Founded 2018 · Delaware corporation · 1 known investors
Founders & leadership
Entasis Therapeutics Holdings was founded in 2018 by Manoussos Perros.
MP
Manoussos PerrosFounder
MG
Michael GutchExecutive
DA
David AltaracExecutive
EK
Elizabeth KeileyExecutive
RT
Ruben TommasiExecutive
JM
John MuellerNamed on SEC filing
DM
David MeekNamed on SEC filing
DH
David HastingsNamed on SEC filing
HM
Howard MayerNamed on SEC filing
HP
Heather PrestonNamed on SEC filing
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$25M disclosed across 1 round · 2020
▶$25MraisedSep 2020 · 2 investors · BiotechnologyRule 506(b)
▶$25MraisedSep 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael GutchExecutive Officer
- John MuellerExecutive Officer
- Heather BehannaDirector
- David AltaracExecutive Officer
- David MeekDirector
- David HastingsDirector
- Elizabeth KeileyExecutive Officer
- Ruben TommasiExecutive Officer
- Howard MayerDirector
- Heather PrestonDirector
- Manoussos PerrosExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $25M
- Sales commissions
- $1.3M
- Placement agents
- A.G.P. / Alliance Global Partner, Cantor Fitzgerald & Co.
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Entasis Therapeutics Holdings?
- Entasis Therapeutics Holdings was founded by Manoussos Perros in 2018.
- Who are Entasis Therapeutics Holdings's investors?
- Entasis Therapeutics Holdings's investors include SR One Capital Management.
- How much funding has Entasis Therapeutics Holdings raised?
- Entasis Therapeutics Holdings has disclosed $25M raised across 1 round.
- Where is Entasis Therapeutics Holdings headquartered?
- Entasis Therapeutics Holdings is headquartered in Waltham, US.